Cytel
Cytel, officially known as Cytel Inc., is a leading provider of advanced statistical software and services, headquartered in the United States. Founded in 1981, the company has established a strong presence in the biostatistics and clinical trial sectors, with major operational regions across North America, Europe, and Asia. Cytel is renowned for its innovative solutions in clinical development, particularly its software products like East and StatXact, which streamline the design and analysis of clinical trials. These offerings are distinguished by their robust statistical methodologies and user-friendly interfaces, catering to the needs of pharmaceutical and biotechnology companies. With a commitment to enhancing the efficiency of clinical research, Cytel has achieved significant milestones, including partnerships with leading global organisations. Its reputation as a trusted partner in the industry underscores its market position and dedication to advancing healthcare through data-driven insights.
DitchCarbon Score
How does Cytel's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cytel's score of 34 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cytel's reported carbon emissions
In 2023, Cytel Inc. reported total greenhouse gas emissions of approximately 1,200,000 kg CO2e, comprising 3,570 kg CO2e from Scope 1, 47,270 kg CO2e from Scope 2 (market-based), and significant contributions from Scope 3 emissions, including 2,196,000 kg CO2e from capital goods, 896,300 kg CO2e from business travel, and 1,072,700 kg CO2e from employee commute. Cytel has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2022 as the base year. Additionally, the company targets a 51.6% reduction in Scope 3 emissions per million USD value added within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to global efforts to limit warming to 1.5°C. Cytel's ongoing commitment to sustainability reflects its proactive approach to addressing climate change and reducing its carbon footprint across all scopes of emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 63,400 | 00,000 | 0,000 |
| Scope 2 | 95,600 | 000,000 | 00,000 |
| Scope 3 | 1,780,900 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cytel is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
